Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus Antrodia Camphorata. The company’s drug, Hocena®, has already received several orphan drug designations and thus far has exhibited promising results in key indications such as pancreatic cancer, non-small cell lung cancer, and even Alzheimer’s disease in animal models.
In the biomedical and healthcare related industries, patients are the center of everything. This industry is more about having as long-term plan to help improve the lives of patients rather than to make money quickly.
